Literature DB >> 2421946

Urinary serotonin in the diagnosis of carcinoid tumors.

J M Feldman.   

Abstract

To determine whether measurement of serotonin in urine would give useful complementary information to the usual measurement of 5-hydroxyindoleacetic acid (5-HIAA) in urine and platelet serotonin in platelets, I measured these analytes in 75 consecutive patients with carcinoid tumors, and found that 75% had above-normal urinary 5-HIAA excretion, 64% had above-normal serotonin excretion, and 64% had above-normal platelet serotonin concentration. Six patients had increased urinary serotonin, but 5-HIAA excretion and platelet serotonin concentration were normal. Only two of a further 50 patients with solid noncarcinoid tumors--and none of 55 patients with flushing or diarrhea, who did not prove to have a carcinoid tumor--had increased urinary serotonin. Ingestion of four bananas (a food rich in serotonin) increased urinary 5-HIAA but not urinary serotonin excretion of seven normal subjects. Evidently, measurement of urinary serotonin excretion is helpful in the evaluation of patients with suspected carcinoid tumors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421946

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

Review 1.  Tubulovillous adenoma of the duodenum: a new etiology for flushing and urinary 5-HIAA elevation.

Authors:  S A Betchen; M Cirigliano; E E Furth; D Broussard; M Grippi; G R Lichtenstein
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

2.  Occult retroperitoneal carcinoid tumor with flushing and solitary lung metastasis.

Authors:  J A Jackson; H D Shipman
Journal:  West J Med       Date:  1989-10

Review 3.  Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms.

Authors:  Irvin M Modlin; Mark Kidd; Pier-Luigi Filosso; Matteo Roffinella; Anna Lewczuk; Jaroslaw Cwikla; Lisa Bodei; Agnieska Kolasinska-Cwikla; Kyung-Min Chung; Margot E Tesselaar; Ignat A Drozdov
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 4.  The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid.

Authors:  W P Tormey; R J FitzGerald
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

5.  Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake.

Authors:  Tisha Joy; Grace Walsh; Sonya Tokmakejian; Stan Hm Van Uum
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

6.  Automated mass spectrometric analysis of urinary and plasma serotonin.

Authors:  Wilhelmina H A de Jong; Marianne H L I Wilkens; Elisabeth G E de Vries; Ido P Kema
Journal:  Anal Bioanal Chem       Date:  2010-02-07       Impact factor: 4.142

7.  Use of somatostatin analog in management of carcinoid syndrome.

Authors:  A Vinik; A R Moattari
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

Review 8.  Current concepts in neuroendocrine cancer metabolism.

Authors:  Joseph E Ippolito
Journal:  Pituitary       Date:  2006       Impact factor: 3.599

9.  Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors.

Authors:  Merete Gedde-Dahl; Espen Thiis-Evensen; Andreas Myklebust Tjølsen; Kjerstin Skrede Mordal; Morten Vatn; Deidi S Bergestuen
Journal:  Endocr Connect       Date:  2013-01-25       Impact factor: 3.335

10.  Carcinoid heart disease.

Authors:  Alain M Bernheim; Heidi M Connolly; Patricia A Pellikka
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.